As the Chief Scientific Officer at Cyagen, Dr. Ouyang oversees the company’s scientific operations and strategic development of genetically engineered mouse model services. With over two decades of experience in the field, Dr. Ouyang has led innovations that have advanced Cyagen’s global leadership in custom model generation.

He is passionate about bridging cutting-edge technologies with translational research to accelerate biomedical discoveries. Before joining Cyagen in 2012, Dr. Ouyang served as the head of Molecular Biology at Taconic Biosciences.

John Merritt, MTM., designs custom animal models and strategies to provide cell therapy companies with contract research services. He has spent over seven years developing pre-clinical assays and has contributed to patenting novel lipid nanoparticles and bioengineering spray-drying techniques specifically for oral drug delivery systems. His academic qualifications include a Master of Translational Medicine from UC Berkeley and UC San Francisco and a Bachelor of Science in Biochemistry from Temple University.